.
MergerLinks Header Logo

New Deal


Announced

Completed

Oppenheimer led a $55m Series C funding round in Perspectum.

Financials

Edit Data
Transaction Value£45m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Biotechnology

Friendly

biotechnology company

United Kingdom

Minority

Cross Border

Acquisition

Private Equity

Private

Completed

Single Bidder

Synopsis

Edit

Oppenheimer, an investment bank, wealth manager company, led a $55m Series C funding round in Perspectum, a medical imaging and diagnostic technology provider. "We congratulate our partner Perspectum on the completion of its Series C funding round and are thrilled to conduct another successful Private Market Opportunity. Medical imaging and diagnostic technology is a highly innovative field, with significant potential for long-term growth that appeals to many of our accredited private investors. This transaction reflects how the full capabilities of Oppenheimer can contribute to better patient care and the development of new therapeutic discoveries," Robert Lowenthal, Oppenheimer President.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US